09/08/17 -
Research
Phase 3 results from EINSTEIN CHOICE clinical trial has revealed patients with venous thromboembolism (VTE) taking Xarelto(rivaroxaban), who received either 10mg or 20mg once daily over an extended...
13/03/17 -
Industry
Izun Pharmaceuticals has announced that the FDA has approved the company’s 510(k) application for Curasite Wound Care Hydrogel. Curasite is a proprietary topical combination of three botanical...
02/08/17 -
Industry
ClotTriever Thrombectomy System
Inari Medical has announced the first patient has been treated with its ClotTriever Thrombectomy System, a non-surgical devices that removes thrombus from the peripheral vasculature. The ClotTriever...
07/03/17 -
Research
The results from the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) randomised, multi-centre clinical trial, has reported that most patients with...
07/03/17 -
Research
As many as three out of four surgery patients could be receiving anti-clotting medications that they do not need, according to a study led by investigators at the University of Utah School of...